Position in CURLF
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,284
New position
Shares Held
600
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Ascentis Independent Advisors holds $313,173 across 19 Drug Manufacturers - Specialty & Generic names. CURLF ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
19,339 | $193,581 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
305 | $40,180 | |
| 3 | ZTS |
Zoetis Inc.
|
182 | $21,512 | |
| 4 | LQDA |
Liquidia Corp
|
391 | $14,756 | |
| 5 | GTBIF |
Green Thumb Industries Inc.
|
1,210 | $7,719 | |
| 6 | VTRS |
Viatris Inc
|
571 | $7,712 | |
| 7 | CRON |
Cronos Group Inc.
|
2,451 | $6,152 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
250 | $5,982 |
All Filings in CURLF
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,284 | 600 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||